Detection of S-Phase Cells and Tumor Marker in Ovarian Carcinoma During Chemothrapy. Immunohistochemical Double Staining With Anti-BrdU Monoclonal Antibody.

The Journal of the Japanese Society of Clinical Cytology
doi 10.5795/jjscc.27.477
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The Japanese Society of Clinical Cytology

Related search

Reactivity of a Monoclonal Antibody With Human Ovarian Carcinoma.

Journal of Clinical Investigation
Medicine
1981English

Analysis of Skin Cancer Using an Anti-BrdU Monoclonal antibody.On Model of Basal Cell Carcinoma.

Skin Cancer
1991English

Immunocytochemical Staining of Breast Carcinoma With the Monoclonal Antibody NCRC 11: A New Prognostic Indicator.

BMJ
1985English

A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients With Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake

Clinical Cancer Research
Cancer ResearchOncology
2005English

Phase 1 Experience With an Anti-Glycotope Monoclonal Antibody, RAV12, in Recurrent Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Anti-Tumor Activity of an Anti-Endoglin Monoclonal Antibody Is Enhanced in Immunocompetent Mice

International Journal of Cancer
Cancer ResearchOncology
2008English

Anti-Human Olig2 Antibody as a Useful Immunohistochemical Marker of Normal Oligodendrocytes and Gliomas

American Journal of Pathology
Forensic MedicinePathology
2004English

Bismuth-213 Radioimmunotherapy With C595 Anti–MUC1 Monoclonal Antibody in an Ovarian Cancer Ascites Model

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2008English

Anti-Cd105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-Gd2 Antibody Immunotherapy of Neuroblastoma With Activated Natural Killer Cells

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy